FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Eron

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Viral Drug Resistance

Anatomy

Semen

Co-author Network

Publications

TOP 3
Mina C Hosseinipour; Joseph J Eron; Ravindra K Gupta; Gert van Zyl; Jean B Nachega
Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings.
Sadeep Shrestha; Joseph J Eron; Derek C Johnson; William C Mathews; Sonia Napravnik; Jill Palchinsky; DC Porter; Erin Reid; Michael S Saag
Short Communication: Lack of Occult HIV Infection Among Non-AIDS-Defining Cancer Patients in Three Academic Oncology Clinics in the United States.
Joseph J Eron; Tamio Fujiwara; Jenny Huang; Christine Katlama; Princy Kumar; Adriano Lazzarin; Sherene Min; Isabelle Poizot-Martin; Gary Richmond; Vincent Soriano; Cindy Vavro; Jane Yeo; Mounir Ait-Khaled; Bonaventura Clotet; Jacques Durant
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Eron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mina C Hosseinipour; Joseph J Eron; Ravindra K Gupta; Gert van Zyl; Jean B Nachega
Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings.
The Journal of infectious diseases 2013;207 Suppl 2():S49-56.
2013: Sadeep Shrestha; Joseph J Eron; Derek C Johnson; William C Mathews; Sonia Napravnik; Jill Palchinsky; DC Porter; Erin Reid; Michael S Saag
Short Communication: Lack of Occult HIV Infection Among Non-AIDS-Defining Cancer Patients in Three Academic Oncology Clinics in the United States.
AIDS research and human retroviruses 2013;29(6):887-91.
2013: Joseph J Eron; Tamio Fujiwara; Jenny Huang; Christine Katlama; Princy Kumar; Adriano Lazzarin; Sherene Min; Isabelle Poizot-Martin; Gary Richmond; Vincent Soriano; Cindy Vavro; Jane Yeo; Mounir Ait-Khaled; Bonaventura Clotet; Jacques Durant
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.
The Journal of infectious diseases 2013;207(5):740-8.
2013: Sonia Napravnik; Timothy R Sterling; Jonathan Uy; Joseph J Eron; Timothy Juday; Richard D Moore
Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort study.
AIDS research and human retroviruses 2013;29(3):574-80.
2013: David A Wohl; Suzanne Blevins; Julie Dumond; Joseph J Eron; Michelle Floris-Moore; Michael G Hudgens; Kelley Massengale; Donna Pittard; David Ragan; Amy Richardson; Kendall Walsh; Ruili Wang; Angela D M Kashuba
Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) study.
Antimicrobial agents and chemotherapy 2013;57(2):784-8.
2013: Prema Menezes; David Rosen; Joseph Sebastian; Joseph J Eron; Nichole Kiziah; David A Wohl; Becky White
Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.
AIDS research and human retroviruses 2013;29(1):136-41.
2013: Mehri S McKellar; Charles B Hicks; Anna B Cope; Joseph J Eron; Guido Ferrari; Susan A Fiscus; Cynthia L Gay; Christopher B Hurt; Melissa G Kerkau; Joann D Kuruc; David M Margolis; Kara S McGee
Acute HIV-1 infection in the Southeastern United States: a cohort study.
AIDS research and human retroviruses 2013;29(1):121-8.
2012: Julie A E Nelson; Norman E Sharpless; Michael G Hudgens; Janakiraman Krishnamurthy; Yan Liu; Prema Menezes; Joseph J Eron
Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy.
Aging cell 2012;11(5):916-8.
2012: Satish Gopal; Kelly E Martin; Kristy L Richards; Joseph J Eron
Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010.
AIDS research and human retroviruses 2012;28(8):798-805.
2012: Gretchen S Arnoczy; Tumena Corrah; Joseph J Eron; Guido Ferrari; Nilu Goonetilleke; Charles Hicks; Joann Kuruc; Hui Li; Kara McGee; John L Schmitz
Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation.
AIDS research and human retroviruses 2012;28(8):789-92.
2012: Nancy M Archin; Ronald J Bosch; S K Choudhary; John M Coffin; A M Crooks; Joseph J Eron; D J Hazuda; M G Hudgens; A D Kashuba; M F Kearney; J D Kuruc; A L Liberty; D C Parker; D D Richman; M C Strain; E M Anderson; David M Margolis
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.
Nature 2012;487(7408):482-5.
2012: Nancie M Archin; Ronald J Bosch; John M Coffin; Myron S Cohen; Joseph J Eron; Cynthia Gay; Mary F Kearney; Joann D Kuruc; Abigail L Liberty; David M Margolis; Naveen K Vaidya; Ann Wiegand; Alan S Perelson
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(24):9523-8.
2012: Marc A Frahm; Cynthia L Gay; Charles B Hicks; JoAnn D Kuruc; Kara S McGee; Ralph A Picking; Georgia D Tomaras; Joseph J Eron; Guido Ferrari
CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(9):4289-96.
2012: Rajesh T Gandhi; Erin A Goecker; Jeffrey M Jacobson; Beatrice Kallungal; Mary Kearney; Michael M Lederman; David M Margolis; John W Mellors; Sarah Read; Ann Wiegand; Lu Zheng; Ronald J Bosch; Ellen S Chan; Ming Chang; Robert W Coombs; Richard D'Aquila; Joseph J Eron
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2012;59(3):229-35.
2011: Christopher B Hurt; Joseph J Eron; Myron S Cohen
Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(12):1265-70.
2011: Babafemi Taiwo; Cara C Wilson; Lu Zheng; Edward P Acosta; Barbara Bastow; Baiba I Berzins; Joseph J Eron; Sebastien Gallien; Peter S Kim; Daniel R Kuritzkes; Roy M Matining
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).
AIDS (London, England) 2011;25(17):2113-22.
2011: Michael J Mugavero; Sonia Napravnik; Michael S Saag; James H Willig; Stephen R Cole; Heidi M Crane; Steven G Deeks; Joseph J Eron; Mari M Kitahata; Bryan Lau; Richard D Moore
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(9):927-35.
2011: Ann M Dennis; Sonia Napravnik; Arlene C Seña; Joseph J Eron
Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(5):480-7.
2011: Babafemi Taiwo; Evgenia Aga; Sebastien Gallien; Richard Haubrich; Daniel R Kuritzkes; Heather Ribaudo; Joseph J Eron
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.
The Journal of infectious diseases 2011;204(4):515-20.
2011: Cynthia Gay; Ashley J Mayo; Chelu K Mfalila; Haitao Chu; Anna C Barry; JoAnn D Kuruc; Kara S McGee; Melissa Kerkau; Joe Sebastian; Susan A Fiscus; David M Margolis; Charles B Hicks; Guido Ferrari; Joseph J Eron
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection.
AIDS (London, England) 2011;25(7):941-9.
2011: Emily Suzanne Brouwer; Sonia Napravnik; Sarah G Smiley; Amanda H Corbett; Joseph J Eron
Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care.
Pharmacoepidemiology and drug safety 2011;20(4):432-9.
2011: Prema Menezes; Joseph J Eron; Peter A Leone; Adaora A Adimora; David A Wohl; William C Miller
Recruitment of HIV/AIDS treatment-naïve patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race.
HIV medicine 2011;12(3):183-91.
2011: Prema Menezes; William C Miller; William C Miller; David A Wohl; Adaora A Adimora; Peter A Leone; Joseph J Eron
Does HAART efficacy translate to effectiveness? Evidence for a trial effect.
PloS one 2011;6(7):e21824.
2011: Cynthia Gay; Oliver Dibben; Jeffrey A Anderson; Andrea Stacey; Ashley J Mayo; Philip J Norris; JoAnn D Kuruc; Jesus F Salazar-Gonzalez; Hui Li; Brandon F Keele; Charles Hicks; David Margolis; Guido Ferrari; Barton Haynes; Ronald Swanstrom; George M Shaw; Beatrice H Hahn; Joseph J Eron; Persephone Borrow; Myron S Cohen
Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.
PloS one 2011;6(5):e19617.
2010: Paul Stewart; Ada Cachafeiro; Sonia Napravnik; Joseph J Eron; Ian Frank; Charles van der Horst; Ronald J Bosch; Daniel Bettendorf; Peter Bohlin; Susan A Fiscus
Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;49(3):198-204.
2010: Mina Hosseinipour; Johnstone J Kumwenda; R Weigel; L B Brown; D Mzinganjira; B Mhango; Joseph J Eron; S Phiri; Joep J G van Oosterhout
Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
HIV medicine 2010;11(8):510-8.
2010: Chanelle J Howe; Stephen R Cole; Sonia Napravnik; Joseph J Eron
Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007.
AIDS research and human retroviruses 2010;26(8):875-81.
2010: Hui Li; Katharine J Bar; shuyi wang; Julie M Decker; Yalu Chen; Chuanxi Sun; Jesus F Salazar-Gonzalez; Maria G Salazar; Gerald Learn; Charity J Morgan; Joseph E Schumacher; Peter T Hraber; Elena E Giorgi; Tanmoy Bhattacharya; Bette T Korber; Alan S Perelson; Joseph J Eron; Myron S Cohen; Charles B Hicks; Barton F Haynes; Martin Markowitz; Brandon F Keele; Beatrice H Hahn; George M Shaw
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.
PLoS pathogens 2010;6(5):e1000890.
2010: Jose M Gatell; Christine Katlama; Beatriz Grinsztejn; Joseph J Eron; Adriano Lazzarin; Daniel Vittecoq; Charles J Gonzalez; Robert M Danovich; Hong Wan; Jing Zhao; Anne R Meibohm; Kim M Strohmaier; Charlotte M Harvey; Robin D Isaacs; Bach-Yen T Nguyen
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.
Journal of acquired immune deficiency syndromes (1999) 2010;53(4):456-63.
2010: Roy T Steigbigel; David A Cooper; Hedy Teppler; Joseph J Eron; Jose M Gatell; Princy N Kumar; Jurgen K Rockstroh; Mauro Schechter; Christine Katlama; Martin Markowitz; Patrick Yeni; Mona R Loutfy; Adriano Lazzarin; Jeffrey Lennox; Bonaventura Clotet; Jing Zhao; Hong Wan; Rand R Rhodes; Kim M Strohmaier; Richard J Barnard; Robin D Isaacs; Bach-Yen Nguyen
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(4):605-12.
2010: Joseph J Eron; Benjamin Young; David A Cooper; Michael Youle; Edwin Dejesus; Jaime Andrade-Villanueva; Cassy Workman; Roberto Zajdenverg; Gerd Fätkenheuer; Daniel S. Berger; Princy N Kumar; Anthony Rodgers; Melissa A Shaughnessy; Monica L Walker; Richard J O Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Xia Xu; Peter Sklar
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.
Lancet 2010;375(9712):396-407.
2010: Stephen R Cole; Sonia Napravnik; Michael J Mugavero; Bryan Lau; Joseph J Eron; Michael S Saag
Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.
American journal of epidemiology 2010;171(2):198-205.
2010: Rajesh T Gandhi; Ronald J Bosch; Evgenia Aga; Mary Albrecht; Lisa M Demeter; Carrie Dykes; Barbara Bastow; Michael Para; Jun Lai; Robert Siliciano; Janet D Siliciano; Joseph J Eron
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
The Journal of infectious diseases 2010;201(2):293-6.
2010: Rajesh T Gandhi; Lu Zheng; Ronald J Bosch; Ellen S Chan; David M Margolis; Sarah Read; Beatrice Kallungal; Sarah Palmer; Kathy Medvik; Michael M Lederman; Nadia Alatrakchi; Jeffrey M Jacobson; Ann Wiegand; Mary Kearney; John M Coffin; John W Mellors; Joseph J Eron
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.
PLoS medicine 2010;7(8):.
2010: Nancie M Archin; Manzoor Cheema; Daniel Parker; Ann Wiegand; Ronald J Bosch; John M Coffin; Joseph J Eron; Myron Cohen; David M Margolis
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection.
PloS one 2010;5(2):e9390.
2010: Sonia Napravnik; Ada Cachafeiro; Paul W. Stewart; Joseph J Eron; Susan A Fiscus
HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;47(1):18-22.
2009: Joseph J Eron
Antiretroviral therapy: new drugs, formulations, ideas, and strategies.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2009;17(5):146-50.
2009: Steven G Deeks; Stephen J Gange; Mari M Kitahata; Michael S Saag; Amy C Justice; Hogg Robert; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Constance A Benson; Ann C Collier; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; Margot B Kushel; James J Goedert; Rosemary G McKaig; Richard D Moore
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1582-90.
2009: Sandra I McCoy; William C Miller; Pia D M MacDonald; Christopher B Hurt; Peter A Leone; Joseph J Eron; Ronald P Strauss
Barriers and facilitators to HIV testing and linkage to primary care: narratives of people with advanced HIV in the Southeast.
AIDS care 2009;21(10):1313-20.
2009: Sandra I McCoy; Ronald P Strauss; Pia D M MacDonald; Peter A Leone; Joseph J Eron; William C Miller
Social support and delays seeking care after HIV diagnosis, North Carolina, 2000-2006.
AIDS care 2009;21(9):1148-56.
2009: Kristine B Patterson; Susan E Cohn; Jennifer Uyanik; Michael Hughes; Marlene Smurzynski; Joseph J Eron
Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(3):473-6.
2009: Marc C Levesque; M Anthony Moody; Kwan-Ki Hwang; Dawn J Marshall; John F Whitesides; Joshua D Amos; Thaddeus C Gurley; Sallie Allgood; Benjamin B Haynes; Nathan A Vandergrift; Steven Plonk; Daniel C Parker; Myron S Cohen; Georgia D Tomaras; Paul A Goepfert; George M Shaw; Joern schmitz; Joseph J Eron; Nicholas J Shaheen; Charles B Hicks; Hua-Xin Liao; Martin Markowitz; Garnett Kelsoe; David M Margolis; Barton F Haynes
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.
PLoS medicine 2009;6(7):e1000107.
2009: Mina Hosseinipour; Joep J G van Oosterhout; Ralf Weigel; Sam Phiri; Debbie Kamwendo; Neil Parkin; Susan A Fiscus; Julie A E Nelson; Joseph J Eron; Johnstone Kumwenda
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.
AIDS (London, England) 2009;23(9):1127-34.
2009: Sandra I McCoy; Joseph J Eron; Joann D Kuruc; Ronald P Strauss; Pia D M MacDonald; Susan A Fiscus; John Barnhart; Christopher D Pilcher; Peter A Leone; William C Miller
Sexually transmitted infections among patients with acute HIV in North Carolina.
Sexually transmitted diseases 2009;36(6):372-4.
2009: Joseph J Eron; Jeong-Gun Park; Richard Haubrich; Francesca T Aweeka; Barbara Bastow; Gary E Pakes; Song Yu; Hulin Wu; Douglas D Richman
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.
Antimicrobial agents and chemotherapy 2009;53(6):2335-41.
2009: Parris S Jordan; Art Poon; Joseph J Eron; Kathleen Squires; Caroline C Ignacio; Douglas D Richman; Davey M Smith
A novel codon insert in protease of clade B HIV type 1.
AIDS research and human retroviruses 2009;25(5):547-50.
2009: William L Ince; Patrick R Harrington; Gretja L Schnell; Milloni Patel-Chhabra; Christina L Burch; Prema Menezes; Richard W Price; Joseph J Eron; Ronald Swanstrom
Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
Journal of virology 2009;83(9):4068-80.
2009: Mari M Kitahata; Stephen J Gange; ALISON ABRAHAM; Barry Merriman; Michael S Saag; Amy C Justice; Hogg Robert; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore
Effect of early versus deferred antiretroviral therapy for HIV on survival.
The New England journal of medicine 2009;360(18):1815-26.
2009: Yvonne Owens Ferguson; Eugenia Eng; Margaret E Bentley; Margarete Sandelowski; Allan Steckler; Elizabeth Randall-David; Ellen G Piwoz; Cynthia Zulu; Charles Chasela; Alice Soko; Martin Tembo; Francis Martinson; Beth Carlton Tohill; Yusuf Ahmed; Peter Kazembe; Denise J Jamieson; Charles van der Horst; Linda S Adair; Yusuf Ahmed; Mounir Ait-Khaled; Sandra Albrecht; Shrikant I Bangdiwala; Ronald Bayer; Margaret Bentley; Brian Bramson; Emily Bobrow; Nicola Boyle; Sal Butera; Charles Chasela; Charity Chavula; Joseph Chimerang'ambe; Maggie Chigwenembe; Maria Chikasema; Norah Chikhungu; David Chilongozi; Grace Chiudzu; Lenesi Chome; Anne Cole; Amanda H Corbett; Amy Corneli; Ann Duerr; Henry Eliya; Sascha Ellington; Joseph J Eron; Sherry Farr; Yvonne Owens Ferguson; Susan A Fiscus; Shannon Galvin; Laura A Guay; Chad Heilig; Irving F Hoffman; Elizabeth Hooten; Mina Hosseinipour; Michael G Hudgens; Stacy Hurst; Lisa Hyde; Denise Jamieson; George Joaki; David Jones; Zebrone Kacheche; Esmie Kamanga; Gift Kamanga; Coxcilly Kampani; Portia Kamthunzi; Deborah Kamwendo; Cecilia Kanyama; Angela D M Kashuba; Damson Kathyola; Dumbani Kayira; Peter N Kazembe; Rodney Knight; Athena Kourtis; Robert Krysiak; Jacob Kumwenda; Edde Loeliger; Misheck Luhanga; Victor Madhlopa; Maganizo Majawa; Alice Maida; Cheryl Marcus; Francis E A Martinson; Navdeep Thoofer; Chrissie Matika; Douglas Mayers; Isabel Mayuni; Marita McDonough; Joyce Meme; Ceppie Merry; Khama Mita; Chimwemwe Mkomawanthu; Gertrude Mndala; Ibrahim Mndala; Agnes Moses; Albans Msika; Wezi Msungama; Beatrice Mtimuni; Jane Muita; Noel Mumba; Bonface Musis; Charles Mwansambo; Gerald Mwapasa; Jacqueline Nkhoma; Richard Pendame; Ellen Piwoz; Byron Raines; Zane Ramdas; John Rublein; Mairin Ryan; Ian Sanne; Christopher Sellers; Diane Shugars; Dorothy Sichali; Wendy Snowden; Alice Soko; Allison Spensley; Jean-Marc Steens; Gerald Tegha; Martin Tembo; Roshan Thomas; Hsiao-Chuan Tien; Beth Tohill; Charles van der Horst; Esther Waalberg; Jeffrey Wiener; Cathy Wilfert; Patricia Wiyo; Onnocent Zgambo; Chifundo Zimba
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.
AIDS education and prevention : official publication of the International Society for AIDS Education 2009;21(2):141-55.
2009: Daniel Westreich; Andrew MacPhail; Annelies van Rie; Babatyi Malope; Prudence Ive; Dennis Rubel; Ronan Boulmé; Joseph J Eron; Ian Sanne
Effect of pulmonary tuberculosis on mortality in patients receiving HAART.
AIDS (London, England) 2009;23(6):707-15.
2009: Cornelius N Van Dam; Samina Syed; Joseph J Eron; Matthew Ostrander; Renata J M Engler; Inger Damon; Jay R Montgomery; Suxiang Tong; Adaora A Adimora; Kevin Kahn; Susan Ruone; Larry Anderson; David J Weber
Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(4):e47-9.
2009: Christopher B Hurt; Sandra I McCoy; Joann Kuruc; Julie A E Nelson; Melissa Kerkau; Susan A Fiscus; Kara McGee; Joseph Sebastian; Peter A Leone; Christopher D Pilcher; Charles Hicks; Joseph J Eron
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007.
Antiviral therapy 2009;14(5):673-8.
2008: Georgia D Tomaras; Nicole L Yates; Pinghuang Liu; Li Qin; Genevieve G Fouda; Leslie L Chavez; Allan C Decamp; Robert J Parks; Vicki C Ashley; Judith T Lucas; Myron Cohen; Joseph J Eron; Charles B Hicks; Hua-Xin Liao; Steven G Self; Gary Landucci; Donald N Forthal; Kent J Weinhold; Brandon F Keele; Beatrice H Hahn; ML Greenberg; Lynn Morris; Salim S Abdool Karim; William A Blattner; David C Montefiori; George M Shaw; Alan S Perelson; Barton F Haynes
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
Journal of virology 2008;82(24):12449-63.
2008: Maya L Petersen; Mark J van der Laan; Sonia Napravnik; Joseph J Eron; Richard D Moore; Steven G Deeks
Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.
AIDS (London, England) 2008;22(16):2097-106.
2008: David A Wohl; David Waters; Ross J Simpson; Susan Richard; Amanda Schnell; Sonia Napravnik; Jessica Keys; Joseph J Eron; Priscilla Y Hsue
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1105-8.
2008: Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2008;300(5):555-70.
2008: Nancy M Archin; Joseph J Eron; Sarah Palmer; Anne Hartmann-Duff; Jeffery A Martinson; Ann Wiegand; Nicholas Bandarenko; John L Schmitz; Ronald J Bosch; Alan L Landay; John M Coffin; David M Margolis
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.
AIDS (London, England) 2008;22(10):1131-5.
2008: Joseph J Eron
Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions.
The Journal of infectious diseases 2008;197 Suppl 3():S261-71.
2008: Bradley N Gaynes; Brian Wells Pence; Joseph J Eron; William C Miller
Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.
Psychosomatic medicine 2008;70(4):505-11.
2008: Sunil Ahuja; Hemant Kulkharni ; Gabriel Catano; Brian Agan; Jose F Camargo; Weijing He; Robert J O'Connell; Vincent Marconi; Judith Delmar; Joseph J Eron; Robert Clark; Simon Frost; Jeffrey Martin; Seema Ahuja; Steven G Deeks; Susan Little; Douglas Richman; Frederick Hecht; Matthew J Dolan
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
Nature medicine 2008;14(4):413-20.
2008: David M Murdoch; Sonia Napravnik; Joseph J Eron; Annelies van Rie
Smoking and predictors of pneumonia among HIV-infected patients receiving care in the HAART era.
The open respiratory medicine journal 2008;2():22-8.
2008: Lisa M Demeter; Victor DeGruttola; Stephanie Lustgarten; Daniel Bettendorf; Margaret A Fischl; Susan H Eshleman; William Spreen; Bach-Yen Nguyen; Christine E Koval; Joseph J Eron; Scott Hammer; Kathleen Squires
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.
HIV clinical trials 2008;9(1):11-25.
2008: Robert L Murphy; Barbara A da Silva; Charles B Hicks; Joseph J Eron; Roy M Gulick; Melanie A Thompson; Florence McMillan; Martin S King; George J Hanna; Scott C Brun
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients.
HIV clinical trials 2008;9(1):1-10.
2007: Kristine B Patterson; Peter A Leone; Susan A Fiscus; Joann Kuruc; Sandra I McCoy; Leslie Wolf; Evelyn Foust; Del Williams; Joseph J Eron; Christopher D Pilcher
Frequent detection of acute HIV infection in pregnant women.
AIDS (London, England) 2007;21(17):2303-8.
2007: Rahul P Bakshi; Fayez M Hamzeh; Ian Frank; Joseph J Eron; Ronald J Bosch; Susan L Rosenkranz; Yoninah S Cramer; Michael Ussery; Charles Flexner
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.
AIDS research and human retroviruses 2007;23(11):1360-5.
2007: Kristine B Patterson; Sonia Napravnik; Joseph J Eron; Jeanne C Keruly; Richard D Moore
Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy.
HIV medicine 2007;8(6):406-10.
2007: Jacques Reynes; Keikawus Arastéh; Bonaventura Clotet; Calvin Cohen; David A Cooper; Jean-François Delfraissy; Joseph J Eron; Keith Henry; Christine Katlama; Daniel R Kuritzkes; Jacob P Lalezari; Joep Lange; Adriano Lazzarin; Julio S G Montaner; Mark Nelson; Mary O' Hearn; Hans-Jürgen Stellbrink; Benoit Trottier; Sharon L Walmsley; Neil E Buss; Ralph DeMasi; Jain Chung; Lucille Donatacci; Denise Guimaraes; Lucy Rowell; Adeline Valentine; Martin Wilkinson; Miklos Salgo
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS patient care and STDs 2007;21(8):533-43.
2007: Daniel Podzamczer; Martin S King; Cheri E Klein; Charles Flexner; Christine Katlama; Diane V Havlir; Scott L Letendre; Joseph J Eron; Scott C Brun; Barry Bernstein
High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response.
HIV clinical trials 2007;8(4):193-204.
2007: Joseph J Eron; Ronald J Bosch; Daniel Bettendorf; Leslie Petch; Susan A Fiscus; Ian Frank
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.
Journal of acquired immune deficiency syndromes (1999) 2007;45(2):249-51.
2007: Joseph J Eron
14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry.
Positively aware : the monthly journal of the Test Positive Aware Network 2007;18(3):31-3.
2007: Sonia Napravnik; Jessica R Keys; E Byrd Quinlivan; David A Wohl; Oksana V Mikeal; Joseph J Eron
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
AIDS (London, England) 2007;21(7):825-34.
2007: Stephen J Gange; Mari M Kitahata; Michael S Saag; david bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Hogg Robert; Michael Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
International journal of epidemiology 2007;36(2):294-301.
2007: Daniel Westreich; Joseph J Eron; Wilfrida Behets; Charles van der Horst; Annelies van Rie
Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
The Journal of infectious diseases 2007;195(6):837-46.
2007: Alan Landay; Barbara A da Silva; Martin S King; Mary Albrecht; Constance Benson; Joseph J Eron; Marshall J Glesby; Roy M Gulick; Charles Hicks; Harold Kessler; Robert Murphy; Melanie Thompson; A Clinton White; Peter Wolfe; Florence I McMillan; George J Hanna
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(5):749-54.
2007: Brian Wells Pence; William C Miller; Bradley N Gaynes; Joseph J Eron
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):159-66.
2007: Jeff D Moore; Edward P Acosta; Victoria A Johnson; Roland Bassett; Joseph J Eron; Margaret A Fischl; Mary C Long; Daniel R Kuritzkes; Jean-Pierre Sommadossi
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Antiviral therapy 2007;12(6):981-6.
2007: Margaret Miles; Diane Holditch-Davis; Cort A Pedersen; Joseph J Eron; Todd A Schwartz
Emotional distress in African American women with HIV.
Journal of prevention & intervention in the community 2007;33(1-2):35-50.
2006: Jeffrey M Jacobson; R Pat Bucy; John Spritzler; Michael S Saag; Joseph J Eron; Robert W Coombs; Rui Wang; Lawrence Fox; Victoria A Johnson; Susan Cu-Uvin; Susan E Cohn; Donna Mildvan; Dorothy O'Neill; Jennifer Janik; Lynette Purdue; Deborah K O'Connor; Christine Di Vita; Ian Frank
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
The Journal of infectious diseases 2006;194(5):623-32.
2006: Joseph J Eron; Patrick Yeni; Joseph C Gathe; Vicente Estrada; Edwin DeJesus; Schlomo Staszewski; Philip Lackey; Christine Katlama; Benjamin Young; Linda Yau; Denise Sutherland-Phillips; Paul Wannamaker; Cindy Vavro; Lisa Patel; Jane Yeo; Mark Shaefer
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
Lancet 2006;368(9534):476-82.
2006: Amanda H Corbett; Kristine B Patterson; Hsiao-Chuan Tien; Leslie A Kalvass; Joseph J Eron; Linh T Ngo; Michael L Lim; Angela D M Kashuba
Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavir.
Antimicrobial agents and chemotherapy 2006;50(8):2756-61.
2006: Thomas Parsons; Karen A Tucker; Colin D Hall; Wendy T Robertson; Joseph J Eron; Michael W Fried; Kevin R Robertson
Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
AIDS (London, England) 2006;20(12):1591-5.
2006: Hulin Wu; Yangxin Huang; Edward P Acosta; Jeong-Gun Park; Song Yu; Susan L Rosenkranz; Daniel R Kuritzkes; Joseph J Eron; Alan S Perelson; John G Gerber
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.
Journal of pharmacokinetics and pharmacodynamics 2006;33(4):399-419.
2006: Nora Franceschini; Sonia Napravnik; William F Finn; Lynda A Szczech; Joseph J Eron
Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):368-72.
2006: Brian Wells Pence; William C Miller; Kathryn Whetten; Joseph J Eron; Bradley N Gaynes
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):298-306.
2006: Nathan Lambert; Brijesh Mehta; Ruth Walters; Joseph J Eron
Chagasic encephalitis as the initial manifestation of AIDS.
Annals of internal medicine 2006;144(12):941-3.
2006: Rosa F Yeh; Vincent E Gaver; Kristine B Patterson; Abdel Naser La Rezk; Faustina Baxter-Meheux; Michael J Blake; Joseph J Eron; Cheri E Klein; John C Rublein; Angela D M Kashuba
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):52-60.
2006: Cynthia Gay; Sonia Napravnik; Joseph J Eron
Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors.
AIDS (London, England) 2006;20(5):775-8.
2006: Dina Hooshyar; Sonia Napravnik; William C Miller; Joseph J Eron
Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV care.
AIDS (London, England) 2006;20(4):575-83.
2006: Sonia Napravnik; Joseph J Eron; Rosemary G McKaig; Amy D Heine; Prema Menezes; E Byrd Quinlivan
Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S.
AIDS care 2006;18 Suppl 1():S45-50.
2006: Kathryn Whetten; Susan Reif; Jan Ostermann; Brian Wells Pence; Marvin Swartz; Rachel Whetten; C Conover; Stephanie Bouis; Nathan M Thielman; Joseph J Eron
Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast.
AIDS care 2006;18 Suppl 1():S18-26.
2005: Brian Wells Pence; Bradley N Gaynes; Kathryn Whetten; Joseph J Eron; Robert W Ryder; William C Miller
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):434-44.
2005: Benoit Trottier; Sharon Walmsley; Jacques Reynes; Peter Piliero; Mary E O'Hearn; Mark Nelson; Julio Montaner; Adriano Lazzarin; Jacob Lalezari; Christine Katlama; Keith Henry; David Cooper; Bonaventura Clotet; Keikawus Arastéh; Jean-François Delfraissy; Hans-Jürgen Stellbrink; Joep Lange; Daniel Kuritzkes; Joseph J Eron; Calvin Cohen; Tosca Kinchelow; Anne Bertasso; Emily Labriola-Tompkins; Anna Shikhman; Belinda Atkins; Laurence Bourdeau; Christopher Natale; Fiona Hughes; Jain Chung; Denise Guimaraes; Claude Drobnes; Silvia Bader-Weder; Ralph Demasi; Lynn Smiley; Miklos P Salgo
Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):413-21.
2005: Mark Nelson; Keikawus Arastéh; Bonaventura Clotet; David A Cooper; Keith Henry; Christine Katlama; Jacob P Lalezari; Adriano Lazzarin; Julio S G Montaner; Mary E O'Hearn; Peter J Piliero; Jacques Reynes; Benoit Trottier; Sharon L Walmsley; Calvin Cohen; Joseph J Eron; Daniel R Kuritzkes; Joep Lange; Hans-Jürgen Stellbrink; Jean-François Delfraissy; Neil E Buss; Lucille Donatacci; Cynthia Wat; Lynn Smiley; Martin Wilkinson; Adeline Valentine; Denise Guimaraes; Ralph DeMasi; Jain Chung; Miklos Salgo
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):404-12.
2005: Melanie A Thompson; Harold A Kessler; Joseph J Eron; Jeffrey M Jacobson; Nathalie Adda; Gong Shen; Jian Zong; Jeanette Harris; Cary Moxham; Franck Rousseau
Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients.
AIDS (London, England) 2005;19(15):1607-15.
2005: Gregory D Sempowski; Charles B Hicks; Joseph J Eron; John A Bartlett; Laura P Hale; Guido Ferrari; Lloyd J Edwards; Susan A Fiscus; Barton F Haynes
Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.
Journal of clinical immunology 2005;25(5):462-72.
2005: Sonia Napravnik; David Edwards; Paul W. Stewart; Brant Stalzer; Elizabeth Matteson; Joseph J Eron
HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):34-40.
2005: Hulin Wu; Yangxin Huang; Edward P Acosta; Susan L Rosenkranz; Daniel R Kuritzkes; Joseph J Eron; Alan S Perelson; John G Gerber
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):272-83.
2005: Christopher D Pilcher; Susan A Fiscus; Trang Q Nguyen; Evelyn Foust; Leslie Wolf; Del Williams; Rhonda Ashby; Judy Owen O'Dowd; J Todd McPherson; Brandt Stalzer; Lisa Hightow-Weidman; William C Miller; Joseph J Eron; Myron S Cohen; Peter A Leone
Detection of acute infections during HIV testing in North Carolina.
The New England journal of medicine 2005;352(18):1873-83.
2005: Nora Franceschini; Sonia Napravnik; Joseph J Eron; Lynda A Szczech; William F Finn
Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.
Kidney international 2005;67(4):1526-31.
2005: Kathryn Whetten; Susan Reif; Marvin Swartz; Rachel Stevens; Jan Ostermann; Laura Hanisch; Joseph J Eron
A brief mental health and substance abuse screener for persons with HIV.
AIDS patient care and STDs 2005;19(2):89-99.
2005: Kathryn Whetten; Susan Reif; Sonia Napravnik; Marvin Swartz; Nathan M Thielman; Joseph J Eron; Kristin Lowe; Tomas Soto
Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.
Southern medical journal 2005;98(1):9-14.
2004: Joseph J Eron; John A Bartlett; Jorge L Santana; Nicholaos C Bellos; Judy Johnson; Amy Keller; Daniel R Kuritzkes; Marty H St Clair; Victoria A Johnson
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1581-3.
2004: Edward P Acosta; Hulin Wu; Scott M Hammer; Song Yu; Daniel R Kuritzkes; Ann Walawander; Joseph J Eron; Carl J Fichtenbaum; Carla Pettinelli; Denise Neath; Elaine Ferguson; Alfred J Saah; John G Gerber
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.
Journal of acquired immune deficiency syndromes (1999) 2004;37(3):1358-66.
2004: Kimberly Ritola; Christopher D Pilcher; Susan A Fiscus; Noah G Hoffman; Julie A E Nelson; Kathryn M Kitrinos; Charles B Hicks; Joseph J Eron; Ronald Swanstrom
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1.
Journal of virology 2004;78(20):11208-18.
2004: Ian Frank; Ronald J Bosch; Susan A Fiscus; Fred Valentine; Charles Flexner; Yoninah Segal; Ping Ruan; Roy M Gulick; Kenneth Wood; Scharla Estep; Lawrence Fox; Thomas Nevin; Michael Stevens; Joseph J Eron
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.
AIDS research and human retroviruses 2004;20(9):916-26.
2004: Robin Wood; Joseph J Eron; Keikawus Arastéh; Eugenio Teofilo; Christian Trepo; Jean-Michel Livrozet; Jane Yeo; Judith Millard; Mary Beth Wire; Odin J Naderer
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):591-4.
2004: Michael L Lim; Sherene S Min; Joseph J Eron; Richard Bertz; Marjorie Robinson; Andrea Gaedigk; Angela D M Kashuba
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1034-40.
2004: Amanda H Corbett; Joseph J Eron; Susan A Fiscus; Abdel Naser La Rezk; Angela D M Kashuba
The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2004;36(4):921-8.
2004: Michael L Tapper; Charles Flexner; Joseph J Eron; Jean-Michael Molina
Simplifying antiretroviral therapy.
The AIDS reader 2004;14(7):355-60, 367-71.
2004: Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W. Stewart; Li-Ean Goh; Myron S Cohen
Brief but efficient: acute HIV infection and the sexual transmission of HIV.
The Journal of infectious diseases 2004;189(10):1785-92.
2004: Francesca Conradie; Ian Sanne; Willem Venter; Joseph J Eron
Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient.
AIDS (London, England) 2004;18(7):1084-5.
2004: Christopher D Pilcher; Joseph J Eron; Shannon Galvin; Cynthia Gay; Myron S Cohen
Acute HIV revisited: new opportunities for treatment and prevention.
The Journal of clinical investigation 2004;113(7):937-45.
2004: Charles Hicks; Martin S King; Roy M Gulick; A Clinton White; Joseph J Eron; Harold A Kessler; Constance Benson; Kathryn R King; Robert L Murphy; Scott C Brun
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study.
AIDS (London, England) 2004;18(5):775-9.
2004: Joseph J Eron; Roy M Gulick; John A Bartlett; Thomas C Merigan; Roberto C Arduino; J. Michael Kilby; Bienvenido Yangco; Adriann Diers; Claude Drobnes; Ralph DeMasi; Michael Greenberg; Tom Melby; Claire Raskino; Pam Rusnak; Ying Zhang; Rebecca Spence; G Diego Miralles
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.
The Journal of infectious diseases 2004;189(6):1075-83.
2004: Christopher D Pilcher; Matthew A Price; Irving F Hoffman; Shannon Galvin; Francis E A Martinson; Peter N Kazembe; Joseph J Eron; William C Miller; Susan A Fiscus; Myron S Cohen
Frequent detection of acute primary HIV infection in men in Malawi.
AIDS (London, England) 2004;18(3):517-24.
2004: Joseph J Eron; Judith Feinberg; Harold A Kessler; Harold W Horowitz; Mallory D Witt; Felix F Carpio; David A Wheeler; Peter Ruane; Donna Mildvan; Bienvenido G Yangco; Richard Bertz; Barry Bernstein; Martin S King; Eugene Sun
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.
The Journal of infectious diseases 2004;189(2):265-72.
2004: Lena Al-Harthi; John C Voris; B K Patterson; STANLEY BECKER; Joseph J Eron; Kimberly Y Smith; R D'Amico; Donna Mildvan; J Snidow; B Pobiner; Linda Yau; Alan Landay
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
HIV medicine 2004;5(1):55-65.
2004: Robin Wood; Keikawus Arastéh; Hans-Jürgen Stellbrink; Eugenio Teofilo; François Raffi; Richard B Pollard; Joseph J Eron; Jane Yeo; Judith Millard; Mary Beth Wire; Odin J Naderer
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 2004;48(1):116-23.
2003: Scott M Hammer; Roland Bassett; Kathleen E Squires; Margaret A Fischl; Lisa M Demeter; Judith S Currier; John W Mellors; Gene D Morse; Joseph J Eron; Jorge L Santana; Victor DeGruttola
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.
Antiviral therapy 2003;8(6):507-18.
2003: Roy M Gulick; Anne R Meibohm; Diane V Havlir; Joseph J Eron; Audrey Mosley; Jeffrey A Chodakewitz; Robin Isaacs; Charles Gonzalez; Douglas McMahon; Douglas D Richman; Michael Robertson; John W Mellors
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
AIDS (London, England) 2003;17(16):2345-9.
2003: Margaret Miles; Diane Holditch-Davis; Joseph J Eron; Beth Perry Black; Cort A Pedersen; Donna A Harris
An HIV self-care symptom management intervention for African American mothers.
Nursing research 2003;52(6):350-60.
2003: Stephanie A Freel; Susan A Fiscus; Christopher D Pilcher; Prema Menezes; Julieta Giner; Ericka Patrick; Jeffrey Lennox; Charles B Hicks; Joseph J Eron; Diane C Shugars
Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.
AIDS (London, England) 2003;17(14):2025-33.
2003: Amy C Weintrob; Julieta Giner; Prema Menezes; Ericka Patrick; Daniel K Benjamin; Jeffrey Lennox; Christopher D Pilcher; Joseph J Eron; Charles B Hicks
Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.
Archives of internal medicine 2003;163(17):2097-100.
2003: Margaret A Fischl; Heather J Ribaudo; Ann C Collier; Alejo Erice; Marina Giuliano; Marjorie Dehlinger; Joseph J Eron; Michael S Saag; Scott M Hammer; STEFANO VELLA; Gene D Morse; Judith E Feinberg; Lisa M Demeter; Susan H Eshleman
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
The Journal of infectious diseases 2003;188(5):625-34.
2003: J. Michael Kilby; Joseph J Eron
Novel therapies based on mechanisms of HIV-1 cell entry.
The New England journal of medicine 2003;348(22):2228-38.
2003: Jacob P Lalezari; Keith Henry; Mary E O'Hearn; Julio S G Montaner; Peter J Piliero; Benoit Trottier; Sharon Walmsley; Calvin Cohen; Daniel R Kuritzkes; Joseph J Eron; Jain Chung; Ralph DeMasi; Lucille Donatacci; Claude Drobnes; John Delehanty; Miklos Salgo
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
The New England journal of medicine 2003;348(22):2175-85.
2003: Jacob P Lalezari; Joseph J Eron; Margrit Carlson; Calvin Cohen; Edwin DeJesus; Roberto C Arduino; Joel E Gallant; Paul A Volberding; Robert L Murphy; Fred Valentine; Emily L Nelson; Prakash Sista; Alex Dusek; J. Michael Kilby
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.
AIDS (London, England) 2003;17(5):691-8.
2003: Lauren Patton; Ronald P Strauss; Rosemary G McKaig; Dawn R Porter; Joseph J Eron
Perceived oral health status, unmet needs, and barriers to dental care among HIV/AIDS patients in a North Carolina cohort: impacts of race.
Journal of public health dentistry 2003;63(2):86-91.
2002: Ole Kirk; Court Pedersen; Matthew Law; Roy M Gulick; Graeme Moyle; Julio Montaner; Joseph J Eron; Andrew N Phillips; Jens D Lundgren
Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy.
Antiviral therapy 2002;7(4):271-81.
2002: Y Sunila Reddy; S Karl Gotzkowsky; Joseph J Eron; Julie Y Kim; William D Fiske; Susan A Fiscus; Leslie Petch; Myron S Cohen; Angela D M Kashuba
Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.
The Journal of infectious diseases 2002;186(9):1339-43.
2002: Naumann I Chaudry; Joseph J Eron; Odin J Naderer; Arlene S Pereira; Mary Beth Wire; Susan A Fiscus; Angela D M Kashuba
Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(6):760-2.
2002: Sonia Napravnik; Charles Poole; James C Thomas; Joseph J Eron
Gender difference in HIV RNA levels: a meta-analysis of published studies.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):11-9.
2002: Arlene S Pereira; Laura M Smeaton; John G Gerber; Edward P Acosta; Snyder Sally; Susan A Fiscus; Richard R Tidwell; Roy M Gulick; Robert L Murphy; Joseph J Eron
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).
The Journal of infectious diseases 2002;186(2):198-204.
2002: Christopher D Pilcher; J Todd McPherson; Peter A Leone; Marlene Smurzynski; Judy Owen-O'Dowd; Amy Brewer; Juanita Harris; Charles B Hicks; Joseph J Eron; Susan A Fiscus
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.
JAMA : the journal of the American Medical Association 2002;288(2):216-21.
2002: Scott M Hammer; Florin Vaida; Kara K Bennett; Mary K Holohan; Lewis B Sheiner; Joseph J Eron; L Joseph Wheat; Ronald T Mitsuyasu; Roy M Gulick; Fred Valentine; Judith A Aberg; Michael D Rogers; Cheryl N Karol; Alfred J Saah; Ronald H Lewis; Laura J Bessen; Carol L Brosgart; Victor DeGruttola; John W Mellors
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
JAMA : the journal of the American Medical Association 2002;288(2):169-80.
2002: J. Michael Kilby; Jacob P Lalezari; Joseph J Eron; Margrit Carlson; Calvin Cohen; Roberto C Arduino; Jeffrey C Goodgame; Joel E Gallant; Paul A Volberding; Robert L Murphy; Fred Valentine; Michael S Saag; Emily L Nelson; Prakash Sista; Alex Dusek
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.
AIDS research and human retroviruses 2002;18(10):685-93.
2002: Constance A Benson; Steven G Deeks; Scott C Brun; Roy M Gulick; Joseph J Eron; Harold A Kessler; Robert L Murphy; Charles Hicks; Martin King; David Wheeler; Judith Feinberg; Richard Stryker; Paul E Sax; Sharon A Riddler; Melanie Thompson; Kathryn Real; Ann Hsu; Dale J Kempf; Anthony J Japour; Eugene Sun
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.
The Journal of infectious diseases 2002;185(5):599-607.
2002: Salisu Garba; Christopher D Pilcher; Andrea L Bingham; Joseph J Eron; Jeffrey Frelinger
HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(5):2247-54.
2002: Joseph J Eron
Expert offers help for PI-related heart disease.
AIDS alert 2002;17(2):26-7, 14.
2002: Arlene S Pereira; Kathryn B Kenney; Myron S Cohen; Joseph J Eron; Richard R Tidwell; John A Dunn
Determination of amprenavir, a HIV-1 protease inhibitor, in human seminal plasma using high-performance liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;766(2):307-17.
2001: Brian M Sadler; Catherine Gillotin; Yu Lou; Joseph J Eron; W Lang; R Haubrich; Daniel S Stein
Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir.
Antimicrobial agents and chemotherapy 2001;45(12):3663-8.
2001: Christopher D Pilcher; Joseph J Eron; P L Vemazza; M Battegay; T Harr; S Yerly; S Vom; L Perrin
Sexual transmission during the incubation period of primary HIV infection.
JAMA : the journal of the American Medical Association 2001;286(14):1713-4.
2001: M A Albrecht; Ronald J Bosch; Scott M Hammer; S H Liou; H Kessler; Michael F Para; Joseph J Eron; Hernan Valdez; Marjorie Dehlinger; David A Katzenstein
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
The New England journal of medicine 2001;345(6):398-407.
2001: R A DeMasi; N M Graham; Jerry M Tolson; Sissi V Pham; G A Capuano; Robin L Fisher; Mark Shaefer; Gary E Pakes; G A Sawyerr; Joseph J Eron
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.
Advances in therapy 2001;18(4):163-73.
2001: Christopher D Pilcher; Diane C Shugars; Susan A Fiscus; William C Miller; Prema Menezes; Julieta Giner; B Dean; Kevin R Robertson; Clyde E Hart; Jeffrey Lennox; Joseph J Eron; Charles B Hicks
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health.
AIDS (London, England) 2001;15(7):837-45.
2001: Huldrych Günthard; Diane V Havlir; Susan A Fiscus; Z Q Zhang; Joseph J Eron; John Mellors; Roy M Gulick; Simon D W Frost; A J Brown; William A Schleif; Fred Valentine; L Jonas; Anne R Meibohm; Caroline C Ignacio; Robin Isaacs; R Gamagami; Emilio A Emini; A Haase; Douglas D Richman; Joseph Wong
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
The Journal of infectious diseases 2001;183(9):1318-27.
2001: Joseph J Eron; Richard Haubrich; W Lang; G Pagano; Judith Millard; J Wolfram; Wendy Snowden; L Pedneault; Margaret Tisdale
A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir.
Journal of acquired immune deficiency syndromes (1999) 2001;26(5):458-61.
2001: Hrishikesh Chakraborty; Pranab Sen; Ronald W Helms; P L Vernazza; Susan A Fiscus; Joseph J Eron; B K Patterson; R W Coombs; J N Krieger; Myron S Cohen
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.
AIDS (London, England) 2001;15(5):621-7.
2001: Roy M Gulick; Laura M Smeaton; Richard T D'Aquila; Joseph J Eron; Judith S Currier; John G Gerber; Edward Acosta; JP Sommadossi; R Tung; Snyder Sally; Daniel R Kuritzkes; Robert L Murphy
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.
The Journal of infectious diseases 2001;183(5):715-21.
2001: Diane C Shugars; Lauren Patton; Stephanie A Freel; Laurie R Gray; R T Vollmer; Joseph J Eron; Susan A Fiscus
Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva.
Journal of dental research 2001;80(2):414-20.
2001: Robert L Murphy; Scott C Brun; Charles Hicks; Joseph J Eron; Roy M Gulick; Martin King; A Clinton White; Constance Benson; Melanie Thompson; Harold A Kessler; S Hammer; Richard Bertz; Ann Hsu; Anthony J Japour; Eugene Sun
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.
AIDS (London, England) 2001;15(1):F1-9.
2001: Joseph J Eron; P Vernazza
Alternative strategies for anti-HIV treatment.
AIDS (London, England) 2001;15 Suppl 5():S161-9.
2000: Li Hua Ping; Myron S Cohen; Irving F Hoffman; P Vernazza; Francoise Seillier-Moiseiwitsch; Hrishikesh Chakraborty; Peter N Kazembe; Dickman Zimba; MJ Maida; Susan A Fiscus; Joseph J Eron; Ronald Swanstrom; Julie A E Nelson
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen.
Journal of virology 2000;74(19):8946-52.
2000: Joseph J Eron; Robert L Murphy; D Peterson; J Pottage; D M Parenti; J Jemsek; S Swindells; G Sepulveda; N Bellos; B C Rashbaum; J Esinhart; N Schoellkopf; R Grosso; M Stevens
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
AIDS (London, England) 2000;14(11):1601-10.
2000: Daniel R Kuritzkes; Roland Bassett; Victoria A Johnson; Ian C Marschner; Joseph J Eron; Jean-Pierre Sommadossi; Edward P Acosta; Robert L Murphy; K Fife; K Wood; Dawn Bell; Ana Martinez; Carla Pettinelli
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
AIDS (London, England) 2000;14(11):1553-61.
2000: Roy M Gulick; John W Mellors; Diane V Havlir; Joseph J Eron; Anne R Meibohm; Jon H Condra; Fred Valentine; Douglas McMahon; Charles Gonzalez; L Jonas; Emilio A Emini; Jeffrey A Chodakewitz; Robin Isaacs; Douglas D Richman
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Annals of internal medicine 2000;133(1):35-9.
2000: Joseph J Eron
HIV-1 protease inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 2():S160-70.
2000: Arlene S Pereira; Kathryn B Kenney; Myron S Cohen; James Edwin Hall; Joseph J Eron; Richard R Tidwell; John A Dunn
Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 2000;742(1):173-83.
2000: Joseph J Eron; Laura M Smeaton; Susan A Fiscus; Roy M Gulick; Judith S Currier; Jeffrey Lennox; Richard T D'Aquila; M D Rogers; R Tung; Robert L Murphy
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
The Journal of infectious diseases 2000;181(5):1622-8.
2000: Joseph J Eron; E S Yetzer; Peter Ruane; STANLEY BECKER; G A Sawyer; Robin L Fisher; Jerry M Tolson; Mark Shaefer
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
AIDS (London, England) 2000;14(6):671-81.
2000: Lauren Patton; Rosemary G McKaig; R Strauss; D Rogers; Joseph J Eron
Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2000;89(3):299-304.
2000: Pietro L Vernazza; L Troiani; Markus Flepp; RW Cone; JL Schock; F Roth; K Boggian; Myron S Cohen; Susan A Fiscus; Joseph J Eron
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(2):117-21.
2000: Daniel R Kuritzkes; D Shugarts; M Bakhtiari; D Poticha; J Johnson; M Rubin; Thomas Gingeras; M Kennedy; Joseph J Eron
Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;23(1):26-34.
1999: Katy H P Moore; G J Yuen; EK Hussey; Gary E Pakes; Joseph J Eron; J A Bartlett
Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.
Antimicrobial agents and chemotherapy 1999;43(12):3025-9.
1999: Arlene S Pereira; Angela D M Kashuba; Susan A Fiscus; James Edwin Hall; Richard R Tidwell; L Troiani; John A Dunn; Joseph J Eron; Myron S Cohen
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
The Journal of infectious diseases 1999;180(6):2039-43.
1999: Lauren Patton; Rosemary G McKaig; Joseph J Eron; H P Lawrence; Ronald P Strauss
Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load.
AIDS (London, England) 1999;13(15):2174-6.
1999: Christopher D Pilcher; Joseph J Eron; L Ngo; A Dusek; Prakash Sista; J Gleavy; D Brooks; T Venetta; E DiMassimo; S Hopkins
Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual.
AIDS (London, England) 1999;13(15):2171-3.
1999: John C Rublein; Joseph J Eron; John D Butts; Ralph H Raasch
Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mg.
The Annals of pharmacotherapy 1999;33(9):899-905.
1999: MR Betts; JF Krowka; Thomas B Kepler; M Davidian; C Christopherson; S Kwok; L Louie; Joseph J Eron; Haynes W Sheppard; Jeffrey Frelinger
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
AIDS research and human retroviruses 1999;15(13):1219-28.
1999: Angela D M Kashuba; JR Dyer; L M Kramer; Ralph H Raasch; Joseph J Eron; Myron S Cohen
Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy 1999;43(8):1817-26.
1999: Li Hua Ping; Julie A E Nelson; Irving F Hoffman; JL Schock; Susanna Lamers; M Goodman; P Vernazza; Peter N Kazembe; MJ Maida; Dickman Zimba; Maureen M Goodenow; Joseph J Eron; Susan A Fiscus; Myron S Cohen; Ronald Swanstrom
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.
Journal of virology 1999;73(8):6271-81.
1999: Christopher D Pilcher; William C Miller; Z A Beatty; Joseph J Eron
Detectable HIV-1 RNA at levels below quantifiable limits by amplicor HIV-1 monitor is associated with virologic relapse on antiretroviral therapy.
AIDS (London, England) 1999;13(11):1337-42.
1999: JR Dyer; Irving F Hoffman; Joseph J Eron; Susan A Fiscus; Myron S Cohen
Immune activation and plasma viral load in HIV-infected African individuals.
AIDS (London, England) 1999;13(10):1283-5.
1999: Christopher D Pilcher; Mark Perkins; Susan A Fiscus; David Johnston; Reynaldo Dietze; U H Duque; AM Zago; F Assad-Antunes; Joseph J Eron
Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.
The Journal of infectious diseases 1999;179(5):1259-63.
1999: Daniel R Kuritzkes; Ian C Marschner; Victoria A Johnson; Roland Bassett; Joseph J Eron; Margaret A Fischl; Robert L Murphy; K Fife; J Maenza; ME Rosandich; Dawn Bell; K Wood; Jean-Pierre Sommadossi; Carla Pettinelli
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators.
AIDS (London, England) 1999;13(6):685-94.
1999: Robert L Murphy; Roy M Gulick; Victor DeGruttola; Richard T D'Aquila; Joseph J Eron; JP Sommadossi; Judith S Currier; Laura M Smeaton; I Frank; A M Caliendo; John G Gerber; R Tung; Daniel R Kuritzkes
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.
The Journal of infectious diseases 1999;179(4):808-16.
1999: Irving F Hoffman; Charles S Jere; Terrie E Taylor; P Munthali; JR Dyer; Jack J Wirima; S J Rogerson; Newton Kumwenda; Joseph J Eron; Susan A Fiscus; Hrishikesh Chakraborty; Taha E Taha; Myron S Cohen; Malcolm E Molyneux
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.
AIDS (London, England) 1999;13(4):487-94.
1999: P L Vernazza; Joseph J Eron; Susan A Fiscus; M S Cohen
Sexual transmission of HIV: infectiousness and prevention.
AIDS (London, England) 1999;13(2):155-66.
1999: JR Dyer; Christopher D Pilcher; RN Shepard; JL Schock; Joseph J Eron; Susan A Fiscus
Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.
Journal of clinical microbiology 1999;37(2):447-9.
1998: Joseph J Eron; Pietro L Vernazza; David Johnston; Francoise Seillier-Moiseiwitsch; TM Alcorn; Susan A Fiscus; Myron S Cohen
Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.
AIDS (London, England) 1998;12(15):F181-9.
1998: Lauren Patton; Rosemary G McKaig; Ronald P Strauss; Joseph J Eron
Oral manifestations of HIV in a southeast USA population.
Oral diseases 1998;4(3):164-9.
1998: Roy M Gulick; John W Mellors; Diane V Havlir; Joseph J Eron; Charles Gonzalez; Douglas McMahon; L Jonas; Anne R Meibohm; Daniel J Holder; William A Schleif; Jon H Condra; Emilio A Emini; Robin Isaacs; Jeffrey A Chodakewitz; Douglas D Richman
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
JAMA : the journal of the American Medical Association 1998;280(1):35-41.
1998: JR Dyer; Peter N Kazembe; Pietro L Vernazza; Bruce L Gilliam; MJ Maida; Dickman Zimba; Irving F Hoffman; Rachel A Royce; JL Schock; Susan A Fiscus; Myron S Cohen; Joseph J Eron
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa.
The Journal of infectious diseases 1998;177(6):1742-6.
1998: Susan A Fiscus; Pietro L Vernazza; Bruce L Gilliam; J Dyer; Joseph J Eron; Myron S Cohen
Factors associated with changes in HIV shedding in semen.
AIDS research and human retroviruses 1998;14 Suppl 1():S27-31.
1998: JR Dyer; Joseph J Eron; Irving F Hoffman; Peter N Kazembe; Pietro L Vernazza; E Nkata; C Costello Daly; Susan A Fiscus; Myron S Cohen
Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi.
The Journal of infectious diseases 1998;177(1):224-7.
1997: Roy M Gulick; John W Mellors; Diane V Havlir; Joseph J Eron; Charles Gonzalez; Douglas McMahon; Douglas D Richman; Fred Valentine; L Jonas; Anne R Meibohm; Emilio A Emini; Jeffrey A Chodakewitz
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
The New England journal of medicine 1997;337(11):734-9.
1997: Scott M Hammer; Kathleen E Squires; Michael D Hughes; J M Grimes; Lisa M Demeter; Judith S Currier; Joseph J Eron; Judith E Feinberg; Henry H Balfour; L R Deyton; J A Chodakewitz; Margaret A Fischl
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
The New England journal of medicine 1997;337(11):725-33.
1997: Pietro L Vernazza; Bruce L Gilliam; Markus Flepp; JR Dyer; A C Frank; Susan A Fiscus; Myron S Cohen; Joseph J Eron
Effect of antiviral treatment on the shedding of HIV-1 in semen.
AIDS (London, England) 1997;11(10):1249-54.
1997: Pietro L Vernazza; JR Dyer; Susan A Fiscus; Joseph J Eron; Myron S Cohen
HIV-1 viral load in blood, semen and saliva.
AIDS (London, England) 1997;11(8):1058-9.
1997: Pietro L Vernazza; Bruce L Gilliam; J Dyer; Susan A Fiscus; Joseph J Eron; A C Frank; Myron S Cohen
Quantification of HIV in semen: correlation with antiviral treatment and immune status.
AIDS (London, England) 1997;11(8):987-93.
1997: Myron S Cohen; Irving F Hoffman; Rachel A Royce; Peter N Kazembe; JR Dyer; CC Daly; Dickman Zimba; Pietro L Vernazza; MJ Maida; Susan A Fiscus; Joseph J Eron
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.
Lancet 1997;349(9069):1868-73.
1997: Bruce L Gilliam; JR Dyer; Susan A Fiscus; C Marcus; S Zhou; L Wathen; William Freimuth; Myron S Cohen; Joseph J Eron
Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(1):54-60.
1997: JR Dyer; Bruce L Gilliam; Joseph J Eron; Myron S Cohen; Susan A Fiscus; Pietro L Vernazza
Shedding of HIV-1 in semen during primary infection.
AIDS (London, England) 1997;11(4):543-5.
1997: Schlomo Staszewski; AM Hill; J Bartlett; Joseph J Eron; Christine Katlama; J Johnson; W Sawyer; H McDade
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.
AIDS (London, England) 1997;11(4):477-83.
1997: Andrew N Phillips; Joseph J Eron; J Bartlett; D R Kuritzkes; V A Johnson; C Gilbert; J Johnson; A Keller; AM Hill
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
AIDS (London, England) 1997;11(2):169-75.
1997: P L Vernazza; Joseph J Eron
Probability of heterosexual transmission of HIV.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(1):85-6.
1996: Joseph J Eron; M A Ashby; M F Giordano; M Chernow; W M Reiter; S G Deeks; J P Lavelle; M A Conant; B G Yangco; P G Pate; R A Torres; R T Mitsuyasu; T Twaddell
Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection.
Lancet 1996;348(9041):1547-51.
1996: Joseph J Eron
The treatment of antiretroviral-naive subjects with the 3TC/zidovudine combination: a review of North American (NUCA 3001) and European (NUCB 3001) trials.
AIDS (London, England) 1996;10 Suppl 5():S11-9.
1996: Daniel R Kuritzkes; J B Quinn; S L Benoit; D L Shugarts; A Griffin; M Bakhtiari; D Poticha; Joseph J Eron; M A Fallon; M Rubin
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.
AIDS (London, England) 1996;10(9):975-81.
1996: JR Dyer; Bruce L Gilliam; Joseph J Eron; L Grosso; Myron S Cohen; Susan A Fiscus
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture.
Journal of virological methods 1996;60(2):161-70.
1996: Andrew N Phillips; Joseph J Eron; J A Bartlett; M Rubin; J Johnson; S Price; P Self; AM Hill
HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
AIDS (London, England) 1996;10(8):859-65.
1996: Katy H P Moore; G J Yuen; Ralph H Raasch; Joseph J Eron; D Martin; P K Mydlow; EK Hussey
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
Clinical pharmacology and therapeutics 1996;59(5):550-8.
1996: Susan A Fiscus; Rachel A Royce; Joseph J Eron
Quality control of HIV cultures in a clinical retrovirology laboratory.
Journal of virological methods 1996;58(1-2):91-8.
1996: Joseph J Eron; Bruce L Gilliam; Susan A Fiscus; J Dyer; Myron S Cohen
HIV-1 shedding and chlamydial urethritis.
JAMA : the journal of the American Medical Association 1996;275(1):36.
1996: P L Vernazza; Joseph J Eron; Susan A Fiscus
Sensitive method for the detection of infectious HIV in semen of seropositive individuals.
Journal of virological methods 1996;56(1):33-40.
1995: Joseph J Eron; S L Benoit; J Jemsek; Rodger D MacArthur; J Santana; J B Quinn; Daniel R Kuritzkes; M A Fallon; M Rubin
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.
The New England journal of medicine 1995;333(25):1662-9.
1995: R R Pogue; Joseph J Eron; Jeffrey Frelinger; M Matsui
Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(18):8166-70.
1994: P L Vernazza; Joseph J Eron; Myron S Cohen; Charles van der Horst; L Troiani; Susan A Fiscus
Detection and biologic characterization of infectious HIV-1 in semen of seropositive men.
AIDS (London, England) 1994;8(9):1325-9.
1994: D Zhang; A M Caliendo; Joseph J Eron; K M DeVore; Jean-Claude Kaplan; Martin S Hirsch; Richard T D'Aquila
Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase.
Antimicrobial agents and chemotherapy 1994;38(2):282-7.
1993: P L Vernazza; Joseph J Eron; Susan A Fiscus
Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count.
The Journal of infectious diseases 1993;168(5):1269-72.
1993: Thomas B Campbell; R K Young; Joseph J Eron; Richard T D'Aquila; W G Tarpley; Daniel R Kuritzkes
Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
The Journal of infectious diseases 1993;168(2):318-26.
1993: Joseph J Eron; Y K Chow; A M Caliendo; J Videler; K M Devore; T P Cooley; Howard A Liebman; Jean-Claude Kaplan; Martin S Hirsch; Richard T D'Aquila
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
Antimicrobial agents and chemotherapy 1993;37(7):1480-7.
1993: Y K Chow; Martin S Hirsch; DP Merrill; L J Bechtel; Joseph J Eron; Jean-Claude Kaplan; Richard T D'Aquila
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Nature 1993;361(6413):650-4.
1992: Joseph J Eron; Victoria A Johnson; DP Merrill; Ting-Chao Chou; Martin S Hirsch
Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.
Antimicrobial agents and chemotherapy 1992;36(7):1559-62.
1992: Joseph J Eron; P Gorczyca; Jean-Claude Kaplan; Richard T D'Aquila
Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3241-5.
1992: P L Williams; R Johnson; Demosthenes Pappagianis; H Einstein; U Slager; F T Koster; Joseph J Eron; J Morrison; J Aguet; M E River
Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(3):673-82.
1991: Victoria A Johnson; DP Merrill; J A Videler; Ting-Chao Chou; R E Byington; Joseph J Eron; Richard T D'Aquila; Martin S Hirsch
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
The Journal of infectious diseases 1991;164(4):646-55.
1991: Richard T D'Aquila; L J Bechtel; J A Videler; Joseph J Eron; P Gorczyca; Jean-Claude Kaplan
Maximizing sensitivity and specificity of PCR by pre-amplification heating.
Nucleic acids research 1991;19(13):3749.
1990: Joseph J Eron; M S Hirsch
New anti-HIV-1 therapies and combinations: current data and prospects.
AIDS (London, England) 1990;4 Suppl 1():S193-200.